Genetic Editing Revolution

CRISPR technology is revolutionizing the treatment of genetic diseases, with successful therapies showing promise in patients with beta thalassemia and sickle cell disease. Remarkably, patients have demonstrated normal to near-normal hemoglobin levels post-treatment, highlighting the potential for eradicating specific genetic disorders. However, the conversation raises concerns about the societal implications of genetic editing, questioning whether it may lead to a loss of individuality in pursuit of an idealized human form.